Yasin Keshvargar
Lawyers
Filters
InflaRx follow-on offering
The shares are listed on the Nasdaq Global Market
Ormat Technologies $297 million follow-on offering
The stock is listed on the NYSE and Tel Aviv Stock Exchange
Alteryx $450 million senior notes offering
The 8.75% notes are due 2028
Stanley Black & Decker $750 million notes offering
The investment-grade notes are due 2026 and 2028
Eli Lilly $4 billion notes offering
The investment-grade notes are due 2026, 2033, 2053 and 2063
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Terns Pharmaceuticals $86 million stock offering
The stock is listed on the Nasdaq Global Select Market
Lantheus Holdings $575 million convertible senior notes offering
The 2.625% convertible notes are due 2027
Brookdale Senior Living $125 million tangible equity units offering
The offering comprised 2.5 million units